DLA
CLX icon

Douglas Lane & Associates’s Clorox CLX Stock Holding History

Douglas Lane & Associates’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-980
Closed -$206K – 215
2020
Q3 		$206K Sell
980
-75
-7% -$16.7K ﹤0.01% 196
2020
Q2 		$231K Buy
+1,055
New +$211K 0.01% 191
2016
Q3 		– Sell
-2,077
Closed -$287K – 209
2016
Q2 		$287K Hold
2,077
– – 0.01% 196
2016
Q1 		$262K Buy
+2,077
New +$264K 0.01% 197

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
CRC
Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Douglas Lane & Associates's CLX Position: Q4 2020 in Review

Douglas Lane & Associates sold out of Clorox (CLX) in Q4 2020, closing a stake of 980 shares — an estimated $206K sold.

Douglas Lane & Associates first reported a position in CLX in Q1 2016 and held it in 4 quarters. The position peaked at $287K in Q2 2016. 1,264 funds tracked by Wall St. Rank hold CLX as of Q4 2020.

  • Douglas Lane & Associates reported no remaining Clorox position as of Q4 2020 after selling out during the quarter.
  • Douglas Lane & Associates sold 980 Clorox shares in Q4 2020, an estimated $206K.
  • Douglas Lane & Associates first reported a position in Clorox in Q1 2016 and held it in 4 quarters.
  • Douglas Lane & Associates's Clorox position peaked at $287K in Q2 2016.
  • 1,264 funds tracked by Wall St. Rank held Clorox as of Q4 2020.

Based on Douglas Lane & Associates's 13F filing for Q4 2020, filed 14 Jan 2021.